Horizontal-Lockup.jpg Horizontal-Lockup.jpg
Horizontal-Lockup.jpg Horizontal-Lockup.jpg
Jami Fukui

Jami A. Fukui, MD

jfukui@cc.hawaii.edu | (808) 441-8199

For all patient related matters: Phone: (808) 586-5854 | Fax: (808) 586-5857

Full Member, Cancer Biology, University of Full Member, Cancer Biology, University of Hawaiʻi Cancer Center
Core Clinical Member, Translational and Clinical Research, University of Hawaiʻi Cancer Center

Academic Appointment(s):
Associate Professor (Associate Researcher), University of Hawaiʻi Cancer Center, University of Hawaiʻi at Mānoa
Chief of Clinical Breast Oncology for Ka ʻUmeke Lama
Assistant Professor, Department of Medicine, John A. Burns School of Medicine, University of Hawaiʻi at Mānoa

Degree(s):

MD, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ
Internal Medicine Residency, Mount Sinai Hospital, New York, NY
Hematology/Oncology Fellowship, Mount Sinai Hospital, New York, NY

Dr. Fukui is an Associate Professor at the University of Hawaiʻi Cancer Center. Her interests are in breast cancer clinical and translational research, developing clinical trial protocols, and providing cancer care to residents of Hawaiʻi.

  1. Tumor microenvironment
    Characterizing the tumor microenvironment (TME) has led to novel therapies in cancer treatment. Within the TME, tumor infiltrating lymphocytes are both predictive of therapy response and prognostic in breast cancer. Evaluating these immune cells can inform clinicians and their patients of potential therapy options and overall outcomes.

  2. Racial/ethnic disparities in breast cancer treatment and outcomes
    Hawaiʻi has one of the highest incidence of breast cancer cases in the U.S. There are accompanying differences in breast cancer mortality according to racial/ethnic group. Evaluating disparities in cancer treatment and coordinating quality improvement for breast cancer care within Hawaii can be achieved through clinical trials.

  3. Lifestyle modification and symptom control in cancer survivors.
    The role of lifestyle modification for prevention of primary breast cancer, secondary cancers and recurrence is an important adjunct to cancer care. Symptom control in cancer patients and survivors can improve therapy adherence and overall quality of life. Clinical trials with patient reported outcomes are increasingly important to capture multiple aspects of patient care.

J. Fukui, PI
Robert A. Winn Excellence in Clinical Trials Award Program-Career Development Award
"Overcoming Barriers to Enhance Breast Cancer Screening Rates among Native Hawaiian and Other Pacific Islander Women"
10/2024 – 09/2026

J. Fukui, Co-Investigator J. Shepherd
L. LeMarchand and J. Berenberg (PIs)
NCI P20CA275734
"Hawaii Minority Health and Cancer Disparities SPORE-project 3"
We will address the very high breast cancer burden of Native Hawaiians and the rising rates in Asian Americans by testing the adequacy of current radiomic risk prediction algorithms for predicting breast cancer in these populations and by investigating related molecular and histopathologic features of breast tumor environment which may be related to visceral adiposity and have prognostic significance.
09/2023 – 07/2026

Takahashi Y, Sridhar N, Iwase T, Marumoto A, Fukui J, Pradhan A, Cheng YC, Ueno NT. (2025) Inflammatory breast cancer, best practice in the community setting. NPJ Breast Cancer. Jun 7;11(1):52. doi: 10.1038/s41523-025-00765-4.PMID: 40483266

Sasaki T, Liyanage A, Bansil S, Silva A, Pagano I, Hidalgo EY, Jones C, Ueno NT, Takahashi Y, Fukui J. (2024). Differences in Breast Cancer Subtypes among Racial/Ethnic Groups. Cancers (Basel). 2024 Oct 12;16(20):3462. doi: 10.3390/cancers16203462

Bansil S, Silva A, Taniguchi A, Wiedmer C, Fernandez M, Pagano I, Vierkoetter K, Killeen J, Fukui J. (2023). Racial/Ethnic Differences Among Tumor-Infiltrating Lymphocytes in Breast Cancer Tumors. Oncologist; Feb 8;28(2):116-122. doi: 10.1093/oncolo/oyac239. PMID: 36495151

Cheng S, Nguyen ET, Pagano I, Fukui JA. (2023) Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients. Oncol Res Treat.; (1-2):26-32. doi: 10.1159/000528578. Epub 2022 Dec 8.PMID: 36481616

Fukui J, White K, Frankland TB, Oshiro C, Wilkens L. (2021). Weight changes according to treatment in a diverse cohort of breast cancer patients. BMC Cancer; Sep 8;21(1):1005. doi: 10.1186/s12885-021-08740-5

Gatti-Mays ME, Balko JM, Gameiro SR, Bear HD, Prabhakaran S, Fukui J, Disis ML, Nanda R, Gulley JL, Kalinsky K, Abdul Sater H, Sparano JA, Cescon D, Page DB, McArthur H, Adams S, Mittendorf EA.(2019) If we build it they will come: targeting the immune response to breast cancer. NPJ Breast Cancer. Oct 29;5:37. doi: 10.1038/s41523-019-0133-7. eCollection 2019.PMID: 31700993

Publication list via PubMed

NCI Breast Cancer Steering Committee member the National Cancer Institute (NCI) Community Oncology Research Program (NCORP) representative
Southwest Oncology Group (SWOG) Supportive Oncology Committee Member
2024 Susan G. Komen Honoree
2025 Hawaiʻi Health Hero